Clinical Trials Directory

Trials / Completed

CompletedNCT00600925

A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection

A Randomized, Controlled, Phase 3 Study of Gentamicin-Collagen Sponge in General Surgical Subjects at Higher Risk for Surgical Wound Infection

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
602 (actual)
Sponsor
Innocoll · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the gentamicin-collagen sponge is safe and effective for preventing surgical wound infections in patients undergoing colorectal surgery.

Detailed description

Surgical wound infection (SWI) is a significant problem in colorectal surgery. Despite the use of routine bowel preparation and prophylactic antibiotics the incidence of SWI is at least 15% in patients undergoing colorectal surgical procedures.Therefore, there is a long unmet need for an intervention that can reduce the incidence and severity of SWIs in patients undergoing colorectal surgery. Gentamicin is an antibiotic that is effective in treating certain kinds of infection. Collagen is a protein that is found in all mammals. The gentamicin-collagen sponge is a thin flat sponge made out of collagen that comes from cow tendons and containing gentamicin. When inserted into a surgical site, the collagen breaks down and the gentamicin is released at the site but very little is absorbed into the blood stream. The high levels of antibiotic at the surgical site may prevent an infection at the surgical site. Outside of the United States more than 3,500 subjects have received treatment in clinical studies with the gentamicin-collagen sponge, primarily for orthopedic, intraabdominal, and cardiothoracic surgeries or wound infections following surgical procedures or traumatic events. In this study, all subjects will be given treatment that is normally given to prevent surgical infections. For subjects randomly assigned to the gentamicin-collagen sponge treatment group, 2 sponges will be inserted into the surgical wound immediately before the surgeon closes it. The control group will receive no collagen sponge.

Conditions

Interventions

TypeNameDescription
DRUGgentamicin-collagen sponge dipped in saline2 gentamicin-collagen sponges inserted before closure of the laparotomy

Timeline

Start date
2008-01-01
Primary completion
2009-03-01
Completion
2010-09-01
First posted
2008-01-25
Last updated
2021-09-24
Results posted
2021-09-24

Locations

39 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00600925. Inclusion in this directory is not an endorsement.